Variant Creutzfeldt-Jakob disease in the United Kingdom: A countrywide or local risk?

Journal of Epidemiology and Community Health

Volumn 64, Issue 7, 2010, Pages 616-621

  Molesworth, Anna M ^a   Cousens, Simon N ^b   Noel, Gill O ^a   Ward, Hester J T ^c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DENTAL HEALTH; DISEASE INCIDENCE; HEALTH CARE; HEALTH RISK; NEUROLOGY; PUBLIC HEALTH; RISK FACTOR;

ANIMAL; ARTICLE; CATTLE; CLUSTER ANALYSIS; CREUTZFELDT JAKOB DISEASE; FOOD HANDLING; HUMAN; MEAT; RISK FACTOR; SLAUGHTERHOUSE; STANDARD; UNITED KINGDOM;

ABATTOIRS; ANIMALS; CATTLE; CLUSTER ANALYSIS; CREUTZFELDT-JAKOB SYNDROME; FOOD HANDLING; GREAT BRITAIN; HUMANS; MEAT; RISK FACTORS;

ENGLAND; LEICESTERSHIRE; UNITED KINGDOM;

EID: 77955634518     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2008.086298     Document Type: Article

References (21)

1. Cousens SN, Everington D, Ward HJT, et al. The geographical distribution of variant Creutzfeldt-Jakob disease cases in the UK: what can we learn from it? Stat Methods Med Res 2003;12:235-46.
2. Monk P, Bryant G. Final report of the investigation into the North Leicestershire cluster of variant Creutzfeldt-Jakob disease Leicestershire NHS Health Authority, Leicester 2001. http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/ 1194947321932 (accessed 14 May 2009).
3. Cousens S, Smith PG, Ward H, et al. Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet 2001;357:1002-7.
4. Spongiform Encephalopathy Advisory Committee. Public summary of the meeting on 25th April 2001. London: Spongiform Encephalopathy Advisory Committee, 2001. http://www.seac.gov.uk/summaries/summ-0401.htm (accessed 22 June 2009).
5. Horby P, Ward H, Cousens S, et al. Protocol for the investigation of geographically associated cases of variant Creutzfeldt-Jakob disease. National vCJD-GAC Investigations Steering Group London, 2001. http://www.cjd.ed.ac.uk/ geo.html (accessed 14 May 2009).
6. Ward HJT, Everington D, Cousens SN, et al. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol 2006;59:111-20.
7. Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000;47:575-82.
8. Kulldorf M, Nagarwalla N. Spatial disease clusters: detection and inference. Stat Med 1995;14:799-810.
9. National CJD Surveillance Unit. Monthly CJD statistics. January 2006. London: Department of Health, 2006. http://www.dh.gov.uk/en/ Publicationsandstatistics/Pressreleases/DH-4126119 (accessed 22 June 2009).
10. Keane D. Report by Mr Desmond Keane, Q.C. to the Mayor and Councillors of the Borough of Llanelli, 29th July 1991. Llanelli: Llanelli Borough Council, 1991.
11. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
12. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9.
13. Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood: a case report. Lancet 2006;368:2061-7.
14. Health Protection Agency. Fourth case of transfusion-associated variant-CJD. Health Protection Report. London: Health Protection Agency, 2007;1.
15. DNV Consulting. Historic Butchery practices in Great Britain. Report to the Food Standards Agency. London: DNV Consulting, 2004 (DNV Report No. 20066400).
16. Prendergast DM, Sheridan JJ, Daly DJ, et al. Dissemination of central nervous system tissue from the brain and spinal cord of cattle after captive bolt stunning and carcass splitting. Meat Sci 2003;65:1201-9.
17. Advisory Committee on Dangerous Pathogens (ACDP)/Spongiform Encephalopathy Advisory Committee (SEAC) Joint Working Group on TSEs. Transmissible spongiform encephalopathy agents: safe working and the prevention of infection. London: Department of Health, 2003. http://www.dh.gov.uk/ab/ACDP/ TSEguidance/index.htm(accessed 22 June 2009).
18. Health Protection Agency. The CJD incidents Panel Framework Document. Management of possible exposure to CJD through medical procedures. London: Health Protection Agency, 2005. http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/ 1194947314514 (accessed 22 June 2009).
19. Spongiform Encephalopathy Advisory Committee. Minutes of the 71st meeting held on 21st November 2001. London: Spongiform Encephalopathy Advisory Committee, 2001. http://www.seac.gov.uk/minutes/mins21-11-01.pdf(accessed 22 June 2009).
20. DNV Consulting. Overview of the risks from BSE via environmental pathways. Compendium of five reports to the Environment Agency. London: DNV Consulting, 1997 (DNV Report No.C7243).
21. Spongiform Encephalopathy Advisory Committee. Summary and minutes of the 82nd meeting held on 29th April 2004. London: Spongiform Encephalopathy Advisory Committee, 2004. http://www.seac.gov.uk/summaries/summ-0404.htmandhttp://www. seac.gov.uk/minutes/final82.pdf(accessed June 2009).